| Phase Ib Study of Efsubaglutide Alfa Injection in Obese Adolescents (NCT07693426) | Shanghai Yinnuo Pharmaceutical Technology Co., Ltd. | 2026-07-16 |
| A Bridging Study of Efsubaglutide Alfa in Healthy Adults in Brazil (NCT07518121) | Shanghai Yinnuo Pharmaceutical Technology Co., Ltd. | 2026-06-01 |
| The Efficacy and Safety of Efsubaglutide Alfa in Overweight/Obesity（SPARKLE） (NCT07114419) | Shanghai Yinnuo Pharmaceutical Technology Co., Ltd. | 2025-08-25 |
| Efficacy and Safety of Efsubaglutide Alfa Injection 3 Mg Q2W in T2D Patients (NCT06900075) | Shanghai Yinnuo Pharmaceutical Technology Co., Ltd. | 2025-07-30 |
| The Efficacy and Safety of Efsubaglutide Alfa Injection in Overweight and Obese Subjects (ENLIGHT) (NCT06921486) | Shanghai Yinnuo Pharmaceutical Technology Co., Ltd. | 2025-03-31 |
| A Study of 3mg Once Every Two Weeks Administration of Efsubaglutide Alfa Injection in Type 2 Diabetes Patients. (NCT06849843) | Shanghai Yinnuo Pharmaceutical Technology Co., Ltd. | 2024-12-18 |
| A Study of the Efficacy and Safety of Efsubaglutide Alfa in Overweight or Obesity Patients (NCT06732960) | Shanghai Yinnuo Pharmaceutical Technology Co., Ltd. | 2024-04-21 |
| Drug Drug Interaction (DDI) Between Supaglutide and Digoxin or Metformin (NCT05694221) | Shanghai Yinnuo Pharmaceutical Technology Co., Ltd. | 2023-03-20 |
| A Study of Efficacy and Safety of Supaglutide in Type 2 Diabetes Patients On Metformin Treatment(SUPER-2) (NCT04998032) | Shanghai Yinnuo Pharmaceutical Technology Co., Ltd. | 2021-10-12 |
| A Study of Efficacy and Safety of Supaglutide in Type 2 Diabetes Patients(SUPER-1) (NCT04994288) | Shanghai Yinnuo Pharmaceutical Technology Co., Ltd. | 2021-08-03 |
| A Study of Supaglutide in Chinese Type 2 Diabetes Patients (NCT04314622) | Shanghai Yinnuo Pharmaceutical Technology Co., Ltd. | 2020-04-14 |
| A Study of the Efficacy and Safety of Supaglutide in Healthy Participants (NCT03745885) | Shanghai Yinnuo Pharmaceutical Technology Co., Ltd. | 2018-12-04 |